Literature DB >> 389812

Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part I: Comparison of the antibacterial effect of sulphonamides alone and in combination with trimethoprim.

B Ekström, U Forsgren, B Ortengren, T Bergan.   

Abstract

Plasma half life and in vitro activity were major criteria for selection of sulphonamides which are likely to give a strong synergistic action with trimethoprim in vivo. On the basis of literature data six sulphonamides, sulphadiazine, sulphachloropyridazine, sulphamethoxazole, sulphaisodimidine, sulphamerazine and sulphamethomidine appeared particularly suitable for combination with trimethoprim. An investigation of the activity in vitro of these compounds and their combinations with the latter against clinically isolated, sulphonamide-sensitive Klebsiella-Enterobacter and Escherichia coli strains showed optimal synergy at trimethoprim-sulphonamide ratios between 1:10 and 1:40, but that appreciable mutual potentiation occurred within a rather broad range of concentration ratios. Limited experiments indicated that synergy occurs less frequently and is less pronounced against sulphonamide resistant bacteria. The different sulphonamides behaved rather similarly in their combinations with trimethoprim, and in order to find the best sulphonamide, detailed comparisons of the pharmacokinetic properties of the different combinations are necessary.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 389812     DOI: 10.1007/bf01639014

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  20 in total

1.  Control of urine pH and its effect on sulfaethidole excretion in humans.

Authors:  H B KOSTENBAUDER; J B PORTNOFF; J V SWINTOSKY
Journal:  J Pharm Sci       Date:  1962-11       Impact factor: 3.534

2.  [Excretion of 6-sulfanilamido-2, 4-dimethylpyrimidine and its acetyl derivatives by normal human kidneys].

Authors:  F PORTWICH; H BUTTNER; J PAULINI
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1955

3.  Pharmacokinetic studies with trimethoprim and different doses of sulfadiazine in healthy human subjects.

Authors:  P Männistö; J Tuomisto; N E Saris; T Lehtinen
Journal:  Chemotherapy       Date:  1973       Impact factor: 2.544

4.  Trimethoprim-sulfamethoxazole: pharmacodynamic effects of urinary pH and impaired renal function. Studies in humans.

Authors:  W A Craig; C M Kunin
Journal:  Ann Intern Med       Date:  1973-04       Impact factor: 25.391

5.  Renal excretion of sulphadimidine in normal and uraemic subjects.

Authors:  E Fischer
Journal:  Lancet       Date:  1972-07-29       Impact factor: 79.321

6.  Pharmacokinetics of the antibacterial combination sulfamethoxazole plus trimethoprim in patients with normal or impaired kidney function.

Authors:  J Rieder; D E Schwartz; M Fernex; T Bergan; E K Brodwall; A Blumberg; P Cottier; W Scheitlin
Journal:  Antibiot Chemother (1971)       Date:  1974

Review 7.  Progress in sulfonamide research.

Authors:  T Struller
Journal:  Prog Drug Res       Date:  1968

8.  Quantitative determination of the bacteriostatically active fraction of sulfonamides and the sum of their inactive metabolites in the body fluids.

Authors:  J Rieder
Journal:  Chemotherapy       Date:  1972       Impact factor: 2.544

9.  Diurnal variations in the elimination rate of a sulfonamide in man.

Authors:  L Dettli; P Spring
Journal:  Helv Med Acta       Date:  1967-01

Review 10.  The pharmacokinetics of trimethoprim and trimethoprim/sulphonamide combinations, including penetration into body tissues.

Authors:  D S Reeves; P J Wilkinson
Journal:  Infection       Date:  1979       Impact factor: 3.553

View more
  5 in total

1.  Trimethoprim/sulphonamide: concluding remarks.

Authors:  W Marget
Journal:  Infection       Date:  1979       Impact factor: 3.553

2.  Comparative pharmacokinetics of co-trifamole and co-trimoxazole to 'steady state' in normal subjects.

Authors:  I D Watson; H N Cohen; M J Stewart; S J McIntosh; A Shenkin; J A Thomson
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

Review 3.  Clinical pharmacokinetics of co-trimazine.

Authors:  T Bergan; B Ortengren; D Westerlund
Journal:  Clin Pharmacokinet       Date:  1986 Sep-Oct       Impact factor: 6.447

Review 4.  Penicillins vs trimethoprim-based regimens for acute bacterial exacerbations of chronic bronchitis: meta-analysis of randomized controlled trials.

Authors:  Ioanna P Korbila; Katerina G Manta; Ilias I Siempos; George Dimopoulos; Matthew E Falagas
Journal:  Can Fam Physician       Date:  2009-01       Impact factor: 3.275

5.  Pharmacokinetics of sulphadiazine, sulphamethoxazole and trimethoprim in patients with varying renal function.

Authors:  T Bergan; E K Brodwall; H Vik-Mo; U Anstad
Journal:  Infection       Date:  1979       Impact factor: 3.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.